(Q38821703)

English

Personalized axillary dissection: the number of excised lymph nodes of nodal-positive breast cancer patients has no significant impact on relapse-free and overall survival

scientific article published on 24 April 2017

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Personalized axillary dissection: the number of excised lymph nodes of nodal-positive breast cancer patients has no significant impact on relapse-free and overall survival (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

0 references

author name string

Florian Ebner

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Achim Wöckel

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Wolfgang Janni

3

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Rolf Kreienberg

4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Lukas Schwentner

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Manfred Wischnewsky

6

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

publication date

24 April 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

New concepts in axillary management of breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Positive lymph nodes do not metastasize

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Completion of axillary dissection for a positive sentinel node: necessary or not?

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Lymph node staging in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer?

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Sentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Targeting Breast Cancer Metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

The seed and soil hypothesis revisited: current state of knowledge of inherited genes on prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Axillary surgery in women with sentinel node-positive operable breast cancer: a systematic review with meta-analyses

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

History of sentinel node and validation of the technique

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2425-3

21 January 2018

Cancer Invasion: Patterns and Mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/28439713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011

1 reference

https://pubmed.ncbi.nlm.nih.gov/28439713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28439713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Importance of lymph node dissection. Worthy of many questions]

1 reference

https://pubmed.ncbi.nlm.nih.gov/28439713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-017-2425-3

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38821703&oldid=2202115807"